Investigation of immunomodulatory effects of hydroxychloroquine on pregnancy outcomes in patients with repeated implantation failure

Phase 2

Recruiting

• Conditions: women infertility.; Complications of attempted introduction of embryo in embryo transfer; N98.3

• Registration Number: IRCT20191231045960N1
• Lead Sponsor: Mashhad University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 24 February 2020

Recruitment & Eligibility

• Status: Recruiting
• Sex: Female
• Target Recruitment: 70

Inclusion Criteria

pregnant woman with lower than 35 years old and 3 unsuccessful IVF in embryo transfer
pregnant woman with greater than 35 years old and 2 unsuccessful IVF in embryo transfer
women with uterine cavity and normal thrombophilia tests and with good-quality embryos

Exclusion Criteria

Drug sensitivity
patient dissatisfaction

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Chemical pregnancy. Timepoint: 14 days after embryo transfer. Method of measurement: Conducting BHCG test.;Implantation rate. Timepoint: 2-4 weeks after BHCG test is positive. Method of measurement: viewing the number of gestational sacs using ultrasound scan.;Clinical pregnancy. Timepoint: 3-5 weeks after BHCG test is positive. Method of measurement: viewing the live fetus using ultrasound scan.